Loading…
Reported covered position: Health Policy Advisor and Counsel, Senate Finance Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| PFIZER |
| 9 |
| 2018–2021 |
| ABBOTT LABORATORIES | 8 | 2019–2021 |
| ALLIANCE OF COMMUNITY HEALTH PLANS | 8 | 2020–2021 |
| KIDNEY CARE COUNCIL | 8 | 2017–2018 |
| OPIOID TREATMENT PROGRAM (OTP) CONSORTIUM | 8 | 2017–2018 |
| UPMC | 8 | 2019–2021 |
| NATIONAL CARDIOVASCULAR PARTNERS | 7 | 2017–2018 |
| UPMC HEALTH PLAN | 7 | 2020–2021 |
| NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION | 6 | 2017–2018 |
| VERAX BIOMEDICAL | 5 | 2017–2018 |
| VISION SERVICE PLAN | 5 | 2018 |
| AMERICAN ORTHOTIC & PROSTHETIC ASSOCIATION | 4 | 2018 |
| BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE | 3 | 2020 |
| MAVERICK CAPITAL | 3 | 2017–2018 |
| U.S. ANESTHESIA PARTNERS, INC. | 3 | 2019–2020 |
| MATRIX MEDICAL NETWORK | 1 | 2017 |
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Paycheck Protection Program and Health Care Enhancement Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Paycheck Protection Program and Health Care Enhancement Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: LINCOLN POLICY GROUP
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: OPTIONCARE HEALTH (FORMERLY OPTION CARE) · Firm: LINCOLN POLICY GROUP
Home Health Prospective Payment System Rate Update for Calendar Year 2020 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: PFIZER · Firm: LINCOLN POLICY GROUP
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Paycheck Protection Program and Health Care Enhancement Act
Client: UPMC · Firm: LINCOLN POLICY GROUP
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: LINCOLN POLICY GROUP
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: SENIOR CARE PHARMACY COALITION · Firm: LINCOLN POLICY GROUP
Issues related to long-term care pharmacies Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Paycheck Protection Program and Health Care Enhancement Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
CARES Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: LINCOLN POLICY GROUP
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Home Health Prospective Payment System Rate Update for Calendar Year 2020 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Issues related to long-term care pharmacies H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
CARES Act
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: LINCOLN POLICY GROUP
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131)
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medicare Advantage Quality Payment Relief Act of 2019
Client: ALLIANCE OF COMMUNITY HEALTH PLANS · Firm: LINCOLN POLICY GROUP
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Prescription Drug Pricing Reduction Act of 2019
Client: AMERISOURCEBERGEN CORPORATION · Firm: LINCOLN POLICY GROUP
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Home Health Prospective Payment System Rate Update for Calendar Year 2020 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Issues related to long-term care pharmacies H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
Dialysis PATIENTS Demonstration Act of 2017
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: LINCOLN POLICY GROUP
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
2021 · third_quarter · 3T
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2021 · third_quarter · Q3
Issues related to long-term care pharmacies COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
COVID relief proposals CY 2022 Home Health Agency Prospective Payment System Proposed Rule--issues related to home infusion therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule COVID relief proposals
CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2021 · third_quarter · 3T
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · second_quarter · Q2
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act COVID relief proposals Issues related to No Surprises Act implementation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to long-term care pharmacies COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
COVID relief proposals CY 2022 Home Health Agency Prospective Payment System Proposed Rule--issues related to home infusion therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule COVID relief proposals
CY 2022 Home Health Aide (HHA) Prospective Payment System Proposed Rule COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System Proposed Rule COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2021 · second_quarter · Q2
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · first_quarter · Q1
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to long-term care pharmacies COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Home Health Prospective Payment System Rate Update for Calendar Year 2020 COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2021 · first_quarter · Q1
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · fourth_quarter · Q4
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Issues related to long-term care pharmacies COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Home Health Prospective Payment System Rate Update for Calendar Year 2020 COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE via LINCOLN POLICY GROUP
2020 · fourth_quarter · 4T
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2020 · fourth_quarter · Q4
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · third_quarter · Q3
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to long-term care pharmacies COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. COVID relief proposals Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Home Health Prospective Payment System Rate Update for Calendar Year 2020 COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model COVID relief proposals
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. COVID relief proposals Issues relating to Medicare Advantage proposed dialysis access policies
BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) COVID relief proposals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2020 · third_quarter · Q3
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BUCHANAN, INGERSOLL, & ROONEY OBO STRATEGIC HEALTH INFO EXCHANGE COLLABORATIVE via LINCOLN POLICY GROUP
2020 · third_quarter · RR
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
Issues related to health information exchanges and accompanying technologies supporting COVID-19 relief efforts and interoperability
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID; General issues related to Medicare and Medicaid; issues related to commercial insurance
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2020 · second_quarter · Q2
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. ANESTHESIA PARTNERS, INC. via LINCOLN POLICY GROUP
2020 · second_quarter · 2T
Medical Billing Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Issues related to long-term care pharmacies Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Home Health Prospective Payment System Rate Update for Calendar Year 2020 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266) Issues relating to Medicare Advantage proposed dialysis access policies
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Paycheck Protection Program and Healthcare Enhancement Act (CARES Act 2.0) (H.R. 266)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2020 · second_quarter · Q2
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
UPMC HEALTH PLAN via LINCOLN POLICY GROUP
2020 · second_quarter · RR
Issues related to COVID-19; issues related to Medicare and Medicaid; issues related to commercial insurance
Issues related to COVID-19; issues related to Medicare and Medicaid; issues related to commercial insurance
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Home Health Prospective Payment System Rate Update for Calendar Year 2020 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2020 · first_quarter · Q1
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
U.S. ANESTHESIA PARTNERS, INC. via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Medical Billing Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Issues related to long-term care pharmacies H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PFIZER via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act Outreach regarding Rare Disease and Part-D copay assistance report language in FY2021 Labor HHS Appropriations cycle Outreach regarding drug supply concerns. Outreach regarding vaccine co-pay language in CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act) Outreach on biosimilar shared savings.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities. H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response Issues relating to Medicare Advantage proposed dialysis access policies
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019 H.R. 748/S. 3548--CARES Act (Coronavirus Aid, Relief, and Economic Security Act) and covid-19 response
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131) Outreach on CARES Act (H.R. 748/S. 3548--Coronavirus Aid, Relief, and Economic Security Act)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2020 · first_quarter · Q1
General healthcare and FDA issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF COMMUNITY HEALTH PLANS via LINCOLN POLICY GROUP
2020 · first_quarter · RR
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131)
General healthcare issues General issues related to Medicaid and Medicare Private Insurance The Medicare Advantage Quality Payment Relief Act (S. 1114/H.R. 2131)
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2019 · fourth_quarter · 4A
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · fourth_quarter · 4A
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · fourth_quarter · 4A
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Q4
Medical billing issues Medicare legislative and regulatory issues S.1895 - Lower Health Care Costs Act H.R.3630 - No Surprises Act
Filing targets: SENATE
U.S. ANESTHESIA PARTNERS, INC. via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Medical Billing Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Issues related to long-term care pharmacies
Filing targets: SENATE
PFIZER via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Issues related to drug pricing S.2543 - Prescription Drug Pricing Reduction Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Issues related to home-infusion therapy requirements. Medicare and Medicaid Programs; CY 2019 Home Health Prospective Payment System Rate Update and CY 2020 Case-Mix Adjustment Methodology Refinements; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; Home Infusion Therapy Requirements; and Training Requirements for Surveyors of National Accrediting Organizations, 83 Fed. Reg. 32,340 (July 12, 2018).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model
CY 2020 Medicare Home Health Prospective Payment System (PPS) rule and the Patient-Driven Groupings Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
Access to regenerative medical technologies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
S. 2065 and H.R. 4143, the Dialysis PATIENTS Demonstration Act; CMS-1691-P: End Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End Stage Renal Disease Quality Incentive Program; and various sub-regulatory guidance from the CMS Centers for Clinical Standards and Quality governing dialysis facility accreditation and dialysis services furnished in skilled nursing facilities.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMERISOURCEBERGEN CORPORATION via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
General healthcare issues S. 2543--Prescription Drug Pricing Reduction Act of 2019
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ABBOTT LABORATORIES via LINCOLN POLICY GROUP
2019 · fourth_quarter · Q4
General healthcare and FDA issues Medical Device Tax
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VISION SERVICE PLAN via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Pub. L. 111-148, the Patient Protection and Affordable Care Act (section 1311); Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010 (section 1406); H.R. 1606, DOC Access Act of 2017; H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act (S. __).
Issues pertaining to tax treatment of employee-sponsored health benefits; Pub. L. 111-148, the Patient Protection and Affordable Care Act; Pub. L. 111-152, the Health Care and Education Reconciliation Act of 2010, provision related to insurer fee; H.R. 246, To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act; H.R. 1628, American Health Care Act, Section 222, Better Care Reconciliation Act (S. __), Sec. 114.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SENIOR CARE PHARMACY COALITION via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Issues related to long-term care pharmacies
Filing targets: SENATE
OPTIONCARE HEALTH (FORMERLY OPTION CARE) via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Issues related to home-infusion therapy requirements. Medicare and Medicaid Programs; CY 2019 Home Health Prospective Payment System Rate Update and CY 2020 Case-Mix Adjustment Methodology Refinements; Home Health Value-Based Purchasing Model; Home Health Quality Reporting Requirements; Home Infusion Therapy Requirements; and Training Requirements for Surveyors of National Accrediting Organizations, 83 Fed. Reg. 32,340 (July 12, 2018).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
OPIOID TREATMENT PROGRAM (OTP) CONSORTIUM via LINCOLN POLICY GROUP
2018 · fourth_quarter · Q4
Medicaid reform, health reform, funding and coverage for opioid use disorder treatment. H.R.6 - SUPPORT for Patients and Communities Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE